Raising Funds for New Product Development and Marketing through a Third-Party Allotment of Stock Acquisition Rights
First written in FY2021-Q2. 12 of 15 entries say "Advanced", first in FY2021-Q3. Latest entry: FY2026.
16 other companies' latest entry also says "Achieved".
- FY2026AchievedAnnual report
「Exercise of the Fifth Series Stock Acquisition Rights was completed on 18 February 2026.」
Cumulative exercise of the Fifth Series Stock Acquisition Rights amounted to 12,500 rights and 1,250,000 shares, raising ¥382 million. Exercise was completed on 18 February 2026. - 2026-05-14AchievedEarningsSuggests it is closing out
「The exercise of the Fifth Stock Acquisition Rights was completed on 18 February 2026.」
Exercise of the Fifth Stock Acquisition Rights was completed, and the company recorded ¥193 million in proceeds from the issuance of shares during the fiscal year. - FY2026-H1AdvancedAnnual report
「Some of the Fifth Series Stock Acquisition Rights issued in August 2024 were exercised during the current interim accounting period, raising ¥119 million. The company is thus also working to strengthen its capital.」
During the interim period, 3,940 Fifth Series Stock Acquisition Rights were exercised, resulting in the delivery of 394,000 shares and fund-raising of ¥119 million. Cumulative funds raised amount to ¥308 million. - FY2025AdvancedAnnual report
「Exercise status during the fiscal year …Fifth Series Stock Acquisition Rights… Number of the relevant stock acquisition rights with exercise conditions exercised during the period (rights): 6,300 …number of shares delivered (shares): 630,000 …funds raised (¥ million): 189」
6,300 Fifth Series Stock Acquisition Rights were exercised, resulting in the delivery of 630,000 shares and fund-raising of ¥189 million. - FY2025-H1AdvancedAnnual report
「Some of the Fifth Series Stock Acquisition Rights issued in August 2024 were exercised during the current interim accounting period, raising ¥54 million. The company is thus also working to strengthen its capital.」
The Fifth Series Stock Acquisition Rights were issued, and 1,800 rights representing 180,000 shares were exercised during the interim period, raising ¥54 million. The new capital-strengthening measure has progressed to the issuance and exercise stages. - FY2024AdvancedAnnual report
「Cumulative number of the relevant stock acquisition rights with an adjustment clause for the exercise price exercised as of the end of the period (rights) 1,730 Cumulative number of shares delivered in connection with the relevant stock acquisition rights with an adjustment clause for the exercise price as of the end of the period (shares) 173,000 Cumulative funds raised through the relevant stock acquisition rights with an adjustment clause for the exercise price as of the end of the period (¥ million) 103」
Cumulative exercise of the Third Series Stock Acquisition Rights amounted to 1,730 rights and 173,000 shares, raising ¥103 million, and capital strengthening is progressing. - FY2024-Q2AdvancedAnnual report
「Some of the Third Series Stock Acquisition Rights issued in March 2022 were exercised during the current second-quarter accounting period, raising ¥96 million.」
The partial exercise of the Third Series Stock Acquisition Rights raised ¥96 million, advancing fund-raising for new product development, marketing and related purposes. - FY2023-Q1AdvancedAnnual report
「During the current first-quarter accounting period, stock acquisition rights attached to bonds with stock acquisition rights with an adjustment clause for the exercise price were exercised as follows.」
130 Third Series Stock Acquisition Rights were exercised, resulting in the delivery of 13,000 shares and fund-raising of ¥7 million. Fund-raising for new product development and marketing is progressing. - FY2022AdvancedAnnual report
「e. Issuance of the Third and Fourth Series Stock Acquisition Rights At a meeting of the Board of Directors held on 16 February 2022, the company resolved to issue the Third and Fourth Series Stock Acquisition Rights by way of a third-party allotment, …and issued them on 7 March 2022.」
Following completion of the exercise of the First and Second Series Stock Acquisition Rights, the company issued the Third and Fourth Series Stock Acquisition Rights representing a total of 1,220,000 shares. Estimated net proceeds were ¥971.473 million. - FY2022-Q3AdvancedAnnual report
「With regard to the Second Series Stock Acquisition Rights issued by the company on 30 November 2020 through a third-party allotment using treasury shares, exercises took place during the period from 1 October to 10 November 2021, as follows.」
During the third-quarter accounting period, 4,800 Second Series Stock Acquisition Rights were exercised, resulting in the delivery of 480,000 shares and fund-raising of ¥368 million. Following the First Series Stock Acquisition Rights, exercise of the Second Series Stock Acquisition Rights was also completed. - FY2022-Q2AdvancedAnnual report
「With regard to the Second Series Stock Acquisition Rights issued by the company on 30 November 2020 through a third-party allotment using treasury shares, exercises took place during the period from 1 October to 10 November 2021, as follows.」
With regard to the Second Series Stock Acquisition Rights, 3,870 rights representing 387,000 shares were exercised between 1 October and 10 November after submission, raising ¥300 million. Fund-raising for the development and marketing of major new products has progressed. - FY2022-Q1AdvancedAnnual report
「Exercise of the First Series Stock Acquisition Rights was completed in June 2021, strengthening the company’s capital.」
With regard to the third-party allotment of Stock Acquisition Rights, exercise of the First Series Stock Acquisition Rights was completed in June 2021, advancing the strengthening of capital. - FY2021AdvancedAnnual report
「Number of stock acquisition rights exercised during the period (rights): 500; number of shares delivered in connection with exercises during the period (shares): 50,000; funds raised through exercises during the period (¥ million): 30」
By the end of the fiscal year, 500 First Series Stock Acquisition Rights had been exercised, 50,000 treasury shares had been delivered, and ¥30 million had been raised. The filing also records the exercise of 3,020 rights, delivery of 302,000 shares and proceeds of ¥188 million from April to 28 June 2021 after submission. - FY2021-Q3AdvancedAnnual report
「With regard to the First Series Stock Acquisition Rights issued by the company on 30 November 2020 through a third-party allotment using treasury shares, with an adjustment clause for the exercise price, a large number were exercised during the period from 1 January to 11 February 2021, as follows.」
The First and Second Series Stock Acquisition Rights were issued on 30 November 2020, and 50,000 shares’ worth of the First Series Stock Acquisition Rights were exercised after the filing was submitted. The fund-raising method for new product development and marketing has progressed to the issuance and exercise stages. - FY2021-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 10 November 2020, the company resolved to issue, by way of a third-party allotment to Mita Securities Co., Ltd. (the “Allottee”), First Series Stock Acquisition Rights (with an adjustment clause for the exercise price, the “First Series Stock Acquisition Rights”) and Second Series Stock Acquisition Rights (with conversion rights to stock acquisition rights with an adjustable exercise price, the “Second Series Stock Acquisition Rights,” and together with the First Series Stock Acquisition Rights, the “Stock Acquisition Rights”), as follows.」
The company newly disclosed plans to issue a total of 9,800 First and Second Series Stock Acquisition Rights, representing 980,000 potential shares, through a third-party allotment. Total proceeds will be ¥1,202,497,200, with estimated net proceeds of ¥1,164,427,200. The exercise period is from 1 December 2020 to 1 December 2023. The funds will be used for new product development and marketing expenses.